NCT05663372View on ClinicalTrials.gov

Bioequivalence Study of Test and Reference 50 mg Eplerenone Film-coated Tablets in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

December 7, 2021

Primary Completion Date

December 28, 2021

Study Completion Date

December 28, 2021

Conditions
BioequivalenceHealthy Subjects
Interventions
DRUG

Efez 50 mg eplerenone film-coated tablets

Oral, mineralocorticoid receptor antagonist, a blocker of aldosterone

DRUG

INSPRA® 50 mg eplerenone film-coated tablets

Oral, mineralocorticoid receptor antagonist, a blocker of aldosterone

Trial Locations (1)

11190

ACDIMA Center for Bioequivalence and Pharmaceutical Studies, Amman

Sponsors
All Listed Sponsors
collaborator

ACDIMA Biocenter

OTHER

lead

Darnitsa Pharmaceutical Company

INDUSTRY

NCT05663372 - Bioequivalence Study of Test and Reference 50 mg Eplerenone Film-coated Tablets in Healthy Volunteers | Biotech Hunter | Biotech Hunter